PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $48,000 | -15.8% | 20,175 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $57,000 | -23.0% | 20,175 | -21.3% | 0.00% | -33.3% |
| Q1 2022 | $74,000 | -5.1% | 25,636 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $78,000 | -43.5% | 25,688 | +30.8% | 0.00% | -40.0% |
| Q3 2021 | $138,000 | -44.1% | 19,635 | -26.9% | 0.01% | -44.4% |
| Q2 2021 | $247,000 | +118.6% | 26,870 | +130.6% | 0.01% | +125.0% |
| Q1 2021 | $113,000 | -19.9% | 11,652 | -15.1% | 0.00% | -33.3% |
| Q4 2020 | $141,000 | – | 13,717 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 507,500 | $121,074,000 | 24.90% |
| BB BIOTECH AG | 476,991 | $113,796,000 | 4.63% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $1,356,668,000 | 3.35% |
| WEATHERBIE CAPITAL, LLC | 101,055 | $24,109,000 | 2.26% |
| Avalon Global Asset Management LLC | 16,000 | $3,817,000 | 2.24% |
| Redmile Group, LLC | 51,025 | $12,173,000 | 1.41% |
| Fernwood Investment Management, LLC | 6,700 | $1,598,000 | 1.38% |
| Iguana Healthcare Management, LLC | 10,000 | $2,386,000 | 1.27% |
| LMR Partners LLP | 56,632 | $13,510,000 | 1.08% |
| FRANKLIN STREET ADVISORS INC /NC | 21,990 | $5,246,000 | 1.00% |